Medidata: Medidata, a Dassault Systèmes brand and a leading provider of clinical trial solutions to the life sciences industry, has introduced two new bundled offerings to meet the growing demands of oncology and vaccine research. Medidata Oncology Solutions and Medidata Vaccine Solutions reinforce the FDA guidance for patient-centered endpoints, adaptive trial designs, and trial diversity. By unifying key trial components such as real-time patient-reported outcomes and imaging management, these bundled solutions will aid sponsors by reducing trial complexity, accelerating decision-making, and improving assessments of treatment efficacy and safety.
According to BERNAMA News Agency, the newly launched bundled solutions are designed to address significant challenges in oncology and vaccine trials, particularly in recruiting diverse patient populations, ensuring rapid execution, and maintaining and monitoring patient safety. Joseph Schmidt, chief operating officer at Medidata, stated that by making these new ca
pabilities readily available, the company can provide a solution built on its extensive experience and expertise in these critical therapeutic areas. The bundles aim to help customers navigate the complicated stages of studies while advancing life-saving treatments.
